SAL |
Hepatic fibrosis/hepatic stellate cell activation |
6.46 |
15.0 |
Role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis |
5.37 |
9.9 |
IL-6 signalling |
4.07 |
14.0 |
Role of osteoblasts, osteoclasts and chondrocytes in rheumatoid arthritis |
3.63 |
9.6 |
Renin–angiotensin signalling |
3.61 |
12.1 |
GNRH signalling |
3.60 |
11.0 |
Xenobiotic metabolism signalling |
2.96 |
8.6 |
Atherosclerosis signalling |
2.95 |
11.2 |
CD27 signalling in lymphocytes |
2.70 |
14.0 |
LPS/IL-1-mediated inhibition of RXR function |
2.68 |
8.7 |
D-UFCB |
Hepatic fibrosis/hepatic stellate cell activation |
2.74 |
11.6 |
Differential regulation of cytokine production in macrophages and T helper cells by IL-17A and IL-17F |
2.63 |
27.8 |
Mitotic roles of polo-like kinase |
2.23 |
14.1 |
Wnt/β-catenin signalling |
2.20 |
10.3 |
Basal cell carcinoma signalling |
1.81 |
12.3 |
Factors promoting cardiogenesis in vertebrates |
1.64 |
10.5 |
D-SWCNT |
TNFR1/TNFR2 signalling |
5.76 |
26.4 |
CD27 signaling in lymphocytes |
4.01 |
21.1 |
Death receptor signalling |
3.98 |
20 |
Chronic myeloid leukaemia signalling |
3.86 |
16.2 |
LPS-stimulated MAPK signalling |
3.56 |
17.1 |
14-3-3-mediated signalling |
3.55 |
15.8 |
Angiopoietin signalling |
3.39 |
17.6 |
Myc-mediated apoptosis signalling |
3.37 |
19.7 |
4-1BB signalling in T lymphocytes |
3.34 |
23.5 |
Apoptosis signalling |
3.14 |
15.6 |
D-MWCNT |
Complement system |
3.24 |
20 |
Role of IL-17A in arthritis |
3.17 |
14.3 |
TNFR1 signalling |
2.98 |
15.1 |
Aminosugars metabolism |
2.76 |
9.17 |
Type II diabetes mellitus signalling |
2.61 |
8.75 |
Atherosclerosis signalling |
2.57 |
10.3 |
LXR/RXR activation |
2.55 |
10.8 |
PTEN signalling |
2.5 |
9.68 |
TWEAK signalling |
2.48 |
15.4 |
LPS/IL-1-mediated inhibition of RXR function |
2.48 |
8.22 |
ASB |
Hepatic fibrosis/stellate cell activation |
8.08 |
13.6 |
TREM1 signalling |
5.30 |
15.2 |
Clathrin-mediated endocytosis signalling |
4.25 |
8.7 |
Complement system |
4.23 |
20.0 |
CTLA4 signalling in cytotoxic T lymphocytes |
3.99 |
11.2 |
Leukocyte extravasation signalling |
3.97 |
8.50 |
Virus entry via endocytic pathways |
3.82 |
11.0 |
NF-κB signalling |
3.74 |
8.52 |
Axonal guidance signalling |
3.68 |
6.0 |
MSP-RON signalling pathway |
3.31 |
13.7 |